Orthopedic Software Market Overview
The Global Orthopedic Software Market size was valued at US$419.5 million in 2025 and is forecast to reach US$782.6 million by 2035, growing at a CAGR of 7.3% during the forecast period 2026-2035.
Orthopedic software refers to specialized computer programs and applications designed to support the workflow and tasks related to orthopedic medicine, which focuses on the treatment of musculoskeletal conditions and injuries. This type of software is used by orthopedic surgeons, healthcare professionals, and administrative staff to streamline various aspects of patient care, management, and documentation within orthopedic practices and hospitals.
Orthopedic software helps in maintaining comprehensive electronic health records (EHR), ensuring that healthcare providers have quick access to patient information. This facilitates better-informed decisions and personalized treatment plans. Integration with imaging tools and PACS allows orthopedic software to handle and analyze medical images effectively. This contributes to more accurate diagnoses and enables surgeons to plan and execute procedures with precision.
Market Scope
| Metrics | Details |
| CAGR | 7.3% |
| Size Available for Years | 2022-2035 |
| Forecast Period | 2026-2035 |
| Data Availability | Value (US$) |
| Segments Covered | Product Type, Mode of Delivery, Application, End-User |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Largest Growing Region | North America |
| Fastest Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details of the report, Request for sample
Market Dynamics:
Drivers
Rising the technological advancements
The medical specialty of orthopaedics focuses on the diagnosis, treatment, and prevention of conditions affecting the musculoskeletal system. Fractures, sprains, and chronic diseases like arthritis are among them. While there are many different ways to treat these diseases, new strategies and methods were made possible by technology advancements.
For instance, according to Orthopaedic Associates of Central Maryland 2023, stated that, instead of importing orthopedic equipment and prosthetics from abroad, three-dimensional (3D) printing allows companies to create them locally. This makes it easier to get access to implants and prosthetics designed specifically for user needs. 3D printing is also used to create preoperative planning surgical guides and models. This not only helps orthopedic surgeons operate accurately and effectively, but it also reduces the risks of complications.
Additionally, new software-based tools are deployed in orthopedics to diagnose and perform surgery and clinical analysis. For examples of this are digital X-rays that produce an image on a computer screen faster than traditional X-rays. This bypasses the chemical processing and production necessary to create the X-ray image, making diagnosis more convenient and efficient. Thus rise of technological advancements helps to accelerates the market growth.
Restraint
Limited reimbursement policies
Limited or inadequate reimbursement for orthopedic software may create financial barriers for healthcare providers. The high upfront costs associated with implementing and maintaining sophisticated software solutions may outweigh the perceived financial benefits, dissuading providers from investing in these technologies. Healthcare organizations often evaluate the return on investment before adopting new technologies.
Smaller orthopedic practices and outpatient facilities, in particular, may be more sensitive to reimbursement issues. Limited financial resources make it challenging for these practices to invest in advanced software solutions, even if they could improve patient care and practice efficiency. Limited reimbursement may discourage software developers from investing in research and development for continuous innovation and upgrades. The lack of financial incentives to improve and expand the capabilities of orthopedic software may lead to stagnation in the market.
Orthopedic Software Market Segment Analysis
The global orthopedic software market is segmented based on product type, mode of delivery, application, end-user and region.
The orthopedic surgical planning software segment from the product type segment accounted for approximately 24.19% of share
Advances in technology, such as improved imaging techniques like 3D and 4D imaging, can lead to the development of more sophisticated orthopedic surgical planning software. New launches may leverage these technological advancements to provide more accurate and detailed preoperative planning. The incorporation of AI and ML algorithms can enhance the capabilities of surgical planning software. New launches may emphasize the use of these technologies to analyze patient data, predict potential complications, and optimize surgical strategies.
Market Geographical Analysis
North America is anticipated to control the orthopedic software market over the forecast period due to the factors such as the rising prevalence of orthopedic disorders, rising strategies by the key players, increasing demand for minimally invasive procedures, and growing technological advancements.
For instance, according to an article published in NIH, estimated that, each year an estimated 1.5 million individuals suffer a fracture due to bone disease. The risk of a fracture increases with age and is greatest in women. Roughly 4 in 10 White women age 50 or older in the United States will experience a hip, spine, or wrist fracture sometime during the remainder of their lives.
COVID-19 Impact Analysis
Coronavirus disease (COVID-19) cases were first reported in China in December 2019 and the World Health Organization declared COVID-19 as a worldwide pandemic on 12 March 2020. The COVID-19 related lockdowns or restrictions have dramatically changed the daily lives of people around the world. It had a major impact on the healthcare system and forced the orthopedic field to execute fundamental changes. The pandemic has widely affected the field of orthopedics.
Most studies have reported that the number of cases in all aspects decreased significantly. Orthopedic education and training, research, and psychological pressure, which have been less noted, have also been significantly impacted. Externally, the overall change seems to be rooted in patients’ fear, lockdowns, and restrictions. Internally, the overall change seems to be attributable to the redeployment or redistribution of personnel in response to the pandemic. In the future, regardless of whether the pandemic has not stopped, it will be important to maintain the normal operation of treatment and surgery to avoid squeal caused by delayed treatment.
Competitive Landscape
The major global players in the market include PrecisionOS, Philips Healthcare, Breg Inc, Kareo, DrChrono, Olympus Corporation, CureMD Healthcare, Exscribe, NextGen Healthcare, Inc, Brainlab AG and among others.
Recent Developments
- Medtronic launched GAiTEWAY: In June 2026, Medtronic launched its cloud-based GAiTEWAY software platform, connecting AI-driven surgical planning, intraoperative technologies and postoperative analytics across its spine ecosystem.
- AI-assisted hip navigation launched: DePuy Synthes announced U.S. commercial availability of VELYS Hip Navigation with AI Assistance in June 2026. The software automates image interpretation and landmark identification for total hip arthroplasty.
- mediCAD 8 introduced AI planning: mediCAD released version 8 in January 2026 with AI-based anatomical landmark recognition for hip, knee and lower-limb planning, targeting faster and more consistent orthopedic surgical preparation.
- FDA De Novo classification for TESSA: In July 2026, Smith+Nephew received FDA De Novo classification for its TESSA Spatial Surgery System, combining AI, personalized planning, augmented reality, imaging, navigation and real-time tracking.
- Additional orthopedic software clearances: FDA records show 2026 clearances for orthopedic digital technologies including Knee+ from Pixee Medical and SCRIPT Implant System from Globus Medical, reflecting continued regulatory activity around computer-assisted orthopedic technologies.
- mediCAD expands internationally: mediCAD reported Canadian-market approval for mediCAD 8 in August 2026 and a new digital orthopedic-planning milestone in Thailand in August 2026, indicating continued international expansion of AI-supported planning software.
Why Purchase the Report?
- To visualize the global orthopedic software market segmentation based on product type, mode of delivery, application, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of orthopedic software market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
